Role of stereotactic radiosurgery in the management of pituitary adenomas

Nature Reviews Endocrinology

Volumn 6, Issue 4, 2010, Pages 214-223

  Castinetti, Frederic ^a   Régis, Jean ^b   Dufour, Henry ^b   Brue, Thierry ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DOPAMINE RECEPTOR STIMULATING AGENT; KETOCONAZOLE; PROLACTIN;

ACROMEGALY; BRAIN INFARCTION; BRAIN NECROSIS; BRAIN TUMOR; CANCER CONTROL; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; DRUG EFFECT; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; HYPOPITUITARISM; INTERMETHOD COMPARISON; LONG TERM CARE; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; RADIATION DOSE; REVIEW; STEREOTACTIC PROCEDURE; TEMPORAL LOBE EPILEPSY; THERAPY EFFECT; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOMA; ALGORITHMS; ANIMALS; COMBINED MODALITY THERAPY; HUMANS; MODELS, BIOLOGICAL; PITUITARY NEOPLASMS; RADIOSURGERY;

EID: 77950300238     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2010.4     Document Type: Review

References (73)

1. Chanson, P. & Salenave, S. Acromegaly. Orphanet J. Rare Dis. 3, 17 (2008).
2. Newell-Price, J., Bertagna, X., Grossman, A. B. & Nieman, L. K. Cushing's syndrome. Lancet 367, 1605-1617 (2006).
3. Brue, T., Delemer, B. & French Society of Endocrinology (SFE) work group on the consensus on hyperprolactinemia. Diagnosis and management of hyperprolactinemia: expert consensus-French Society of Endocrinology. Ann. Endocrinol. (Paris) 68, 58-64 (2007).
4. Dekkers, O. M., Pereira, A. M. & Romijn, J. A. Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J. Clin. Endocrinol. Metab. 93, 3717-3726 (2008).
5. Eastman, R. C., Gorden, P., Glatstein, E. & Roth, J. Radiation therapy of acromegaly. Endocrinol. Metab. Clin. North Am. 21, 693-712 (1992).
6. Minniti, G., Gilbert, D. C. & Brada, M. Modern techniques for pituitary radiotherapy. Rev. Endocr. Metab. Disord. 10, 135-144 (2009).
7. Brada, M. & Jankowska, P. Radiotherapy for pituitary adenomas. Endocrinol. Metab. Clin. North Am. 37, 263-275 (2008).
8. Chen, C. C., Chapman, P., Petit, J. & Loeffler, J. Proton radiosurgery in neurosurgery. Neurosurg. Focus 23, E5 (2007).
9. Adler, J. R. Jr, Gibbs, I. C., Puataweepong, P. & Chang, S. D. Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 59, 244-254 (2006).
10. Tuniz, F. et al. Multisession cyberknife stereotactic radiosurgery of large, benign cranial base tumors: preliminary study. Neurosurgery 65, 898-907 (2009).
11. Castinetti, F., Morange, I., Dufour, H., Regis, J. & Brue, T. Radiotherapy and radiosurgery in acromegaly. Pituitary 12, 3-10 (2009).
12. Castinetti, F. et al. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J. Clin. Endocrinol. Metab. 94, 3400-3407 (2009).
13. Ronchi, C. L. et al. Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study. Clin. Endocrinol. (Oxf.) 71, 846-852 (2009).
14. Pouratian, N. et al. Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59, 255-266 (2006).
15. Jagannathan, J. et al. Gamma knife surgery for Cushing's disease. J. Neurosurg. 106, 980-987 (2007).
16. Jagannathan, J. et al. Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery 62, 1262-1270 (2008).
17. Jezkova ́, J. et al. Use of the Leksell gamma knife in the treatment of prolactinoma patients. Clin. Endocrinol. (Oxf.) 70, 732-741 (2008).
18. Jezkova ́, J. et al. Gamma knife radiosurgery for acromegaly--long-term experience. Clin. Endocrinol. (Oxf.) 64, 588-595 (2006).
19. Vik-Mo, E. O. et al. Gamma knife stereotactic radiosurgery for acromegaly. Eur. J. Endocrinol. 157, 255-263 (2007).
20. Pollock, B. E., Jacob, J. T., Brown, P. D. & Nippoldt, T. B. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J. Neurosurg. 106, 833-838 (2007).
21. Losa, M. et al. The role of stereotactic radiotherapy in patients with growth hormonesecreting pituitary adenoma. J. Clin. Endocrinol. Metab. 93, 2546-2552 (2008).
22. Laws, E. R. et al. Stereotactic radiosurgery for pituitary adenomas: a review of the literature. J. Neurooncol. 69, 257-272 (2004).
23. Castinetti, F. et al. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J. Clin. Endocrinol. Metab. 90, 4483-4488 (2005).
24. Landolt, A. M. et al. Octreotide may act as a radioprotective agent in acromegaly. J. Clin. Endocrinol. Metab. 85, 1287-1289 (2000).
25. Kobayashi, T., Kida, Y. & Mori, Y. Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. J. Neurosurg. 97 (Suppl. 5), 422-428 (2002).
26. Ho ̈ybye, C. et al. Adrenocorticotropic hormoneproducing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49, 284-292 (2001).
27. Castinetti, F., Morange, I., Jaquet, P., Conte-Devolx, B. & Brue, T. Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease. Eur. J. Endocrinol. 158, 91-99 (2008).
28. Castinetti, F. et al. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. Eur. J. Endocrinol. 156, 91-98 (2007).
29. Stalla, G. K., Stalla, J., Loeffler, J. P., Von werder, K. & Mu ̈ller, O. A. Pharmacological modulation of CRH-stimulated ACTH secretion by ketoconazole. Horm. Metab. Res. Suppl. 16, 31-36 (1987).
30. Pan, L. et al. Gamma knife radiosurgery as a primary treatment for prolactinomas. J. Neurosurg. 93 (Suppl. 3), 10-13 (2000).
31. Landolt, A. M. & Lomax, N. Gamma knife radiosurgery for prolactinomas. J. Neurosurg. 93 (Suppl. 3), 14-18 (2000).
32. Sheehan, J. P., Jagannathan, J., Pouratian, N. & Steiner, L. Stereotactic radiosurgery for pituitary adenomas: a review of the literature and our experience. Front. Horm. Res. 34, 185-205 (2006).
33. Pamir, M. N., Kilic ̧, T., Belirgen, M., Abacioglu, U. & Karabekiroglu, N. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up. Neurosurgery 61, 270-280 (2007).
34. Pollock, B. E. et al. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int. J. Radiat. Oncol. Biol. Phys. 70, 1325-1329 (2008).
35. Ho ̈ybye, C. & Ra ̈hn, T. Adjuvant Gamma Knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients. Pituitary 12, 211-216 (2009).
36. Mingione, V. et al. Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J. Neurosurg. 104, 876-883 (2006).
37. Castinetti, F. et al. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J. Clin. Endocrinol. Metab. 90, 4483-4488 (2005).
38. Brada, M., Ajithkumar, T. V. & Minniti, G. Radiosurgery for pituitary adenomas. Clin. Endocrinol. (Oxf.) 61, 531-543 (2004).
39. Tishler, R. B. et al. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 27, 215-221 (1993).
40. Jagannathan, J., Yen, C. P., Pouratian, N., Laws, E. R. & Sheehan, J. P. Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife. J. Neurooncol. 92, 345-356 (2009).
41. Rowe, J. et al. Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60, 60-66 (2007).
42. Voges, J. et al. Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 107, 1355-1364 (2006).
43. Chen, C. C., Chapman, P., Petit, J. & Loeffler, J. Proton radiosurgery in neurosurgery. Neurosurg. Focus 23, E5 (2007).
44. Petit, J. H. et al. Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr. Pract. 13, 726-734 (2007).
45. Aghi, M. K. et al. Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. Clin. Neurosurg. 55, 141-144 (2008).
46. Kim, J. W. et al. Preliminary report of multisession gamma knife radiosurgery for benign perioptic lesions: visual outcome in 22 patients. J. Korean Neurosurg. Soc. 44, 67-71 (2008).
47. Knisely, J. P., Bond, J. E., Yue, N. J., Studholme, C. & de Lotbinie ̀re, A. C. Image registration and calculation of a biologically effective dose for multisession radiosurgical treatments. Technical note. J. Neurosurg. 93 (Suppl. 3), 208-218 (2000).
48. Estrada, J. et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N. Engl. J. Med. 336, 172-177 (1997).
49. Jenkins, P. J., Bates, P., Carson, M. N., Stewart, P. M. & wass, J. A. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J. Clin. Endocrinol. Metab. 91, 1239-1245 (2006).
50. McCord, M. W. et al. Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int. J. Radiat. Oncol. Biol. Phys. 39, 437-444 (1997).
51. Biermasz, N. R., van Dulken, H. & Roelfsema, F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J. Clin. Endocrinol. Metab. 85, 2476-2482 (2000).
52. Barrande, G. et al. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J. Clin. Endocrinol. Metab. 85, 3779-3785 (2000).
53. Sonino, N., Zielezny, M., Fava, G. A., Fallo, F. & Boscaro, M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J. Clin. Endocrinol. Metab. 81, 2647-2652 (1996).
54. al-Mefty, O., Kersh, J. E., Routh, A. & Smith, R. R. The long-term side effects of radiation therapy for benign brain tumors in adults. J. Neurosurg. 73, 502-512 (1990).
55. Mokry, M., Ramschak-Schwarzer, S., Simbrunner, J., Ganz, J. C. & Pendl, G. A six year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotact. Funct. Neurosurg. 72 (Suppl. 1), 88-100 (1999).
56. Brada, M. et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304, 1343-1346 (1992).
57. Erfurth, E. M., Bu ̈low, B., Mikoczy, Z., Svahn-Tapper, G. & Hagmar, L. Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour? Clin. Endocrinol. (Oxf.) 55, 613-616 (2001).
58. Tsang, R. W. et al. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 72, 2227-2233 (1993).
59. Colin, P. et al. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int. J. Radiat. Oncol. Biol. Phys. 62, 333-341 (2005).
60. Minniti, G., Traish, D., Ashley, S., Gonsalves, A. & Brada, M. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin. Endocrinol. (Oxf.) 64, 542-548 (2006).
61. Biermasz, N. R., Van Dulken, H. & Roelfsema, F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J. Clin. Endocrinol. Metab. 85, 4596-4602 (2000).
62. Freda, P. U., Wardlaw, S. L. & Post, K. D. Longterm endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J. Neurosurg. 89, 353-358 (1998).
63. Swearingen, B. et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 83, 3419-3426 (1998).
64. Shimon, I., Cohen, Z. R., Ram, Z. & Hadani, M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48, 1239-1245 (2001).
65. Atkinson, A. B., Kennedy, A., wiggam, M. I., McCance, D. R. & Sheridan, B. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clin. Endocrinol. (Oxf.) 63, 549-559 (2005).
66. Chee, G. H., Mathias, D. B., James, R. A. & Kendall-Taylor, P. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin. Endocrinol. (Oxf.) 54, 617-626 (2001).
67. Rees, D. A. et al. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin. Endocrinol. (Oxf.) 56, 541-551 (2002).
68. Shimon, I., Ram, Z., Cohen, Z. R. & Hadani, M. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 51, 57-62 (2002).
69. Utz, A. L., Swearingen, B. & Biller, B. M. Pituitary surgery and postoperative management in Cushing's disease. Endocrinol. Metab. Clin. North Am. 34, 459-478 (2005).
70. Melmed, S. et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509-1517 (2009).
71. Casanueva, F. F. et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin. Endocrinol. (Oxf.) 65, 265-273 (2006).
72. Biller, B. M. et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 93, 2454-2462 (2008).
73. Dekkers, O. M., Pereira, A. M. & Romijn, J. A. Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J. Clin. Endocrinol. Metab. 93, 3717-3726 (2008).